About the Authors
- Grzegorz Kijanka
-
Affiliation Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
- Malgorzata Prokopowicz
-
Affiliation Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
- Huub Schellekens
-
Affiliations Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands, Department of Innovation Management, Utrecht University, Utrecht, The Netherlands
- Vera Brinks
-
* E-mail: V.Brinks@uu.nl
Affiliation Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
Competing Interests
Grzegorz Kijanka and Malgorzata Prokopowicz declare no financial and commercial conflict of interest. Vera Brinks and Huub Schellekens have participated in meetings and publications sponsored by Amgen, Genzyme, Pfizer, Johnson & Johnson, Roche, Sandoz and Hospira. Part of this research is directly or indirectly sponsored by Roche and Amgen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GK VB. Performed the experiments: GK MP. Analyzed the data: GK MP. Wrote the paper: GK VB. Discussed the results and commented on the manuscript: HS.